Heights Capital Management’s CalciMedica CALC Stock Holding History
Bought
Maintained
Sold
Other funds holding CALC
Heights Capital Management's CALC Position: Q3 2026 in Review
Heights Capital Management reduced its CalciMedica (CALC) stake by 47% in Q3 2026, selling an estimated $454K and leaving 163,728 shares worth $265K. The position accounts for 0.05% of the portfolio, ranked #194.
Heights Capital Management first reported a position in CALC in Q2 2026 and has held it in 2 quarters since. The position peaked at $1.6M in Q2 2026. 17 funds tracked by Wall St. Rank hold CALC as of Q3 2026.
- Heights Capital Management held 163,728 shares of CalciMedica worth $265K as of Q3 2026.
- Heights Capital Management sold 147,488 CalciMedica shares in Q3 2026, an estimated $454K.
- CalciMedica made up 0.05% of Heights Capital Management's portfolio in Q3 2026, its #194 holding.
- Heights Capital Management first reported a position in CalciMedica in Q2 2026 and has held it in 2 quarters since.
- Heights Capital Management's CalciMedica position peaked at $1.6M in Q2 2026.
- 17 funds tracked by Wall St. Rank held CalciMedica as of Q3 2026.
Based on Heights Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.